Curaleaf (OTCMKTS:CURLF) Shares Gap Down – Here’s Why

Curaleaf Holdings, Inc. (OTCMKTS:CURLF)’s stock price gapped down before the market opened on Friday . The stock had previously closed at $9.37, but opened at $9.00. Curaleaf shares last traded at $9.20, with a volume of 9,220 shares.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised Curaleaf from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, July 14th. Three investment analysts have rated the stock with a Strong Buy rating and one has given a Buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Strong Buy”.

Curaleaf Stock Performance

The stock has a market cap of $2.12 billion, a PE ratio of -23.26 and a beta of 1.51. The firm’s 50-day moving average is $7.27 and its 200 day moving average is $7.62. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.74 and a current ratio of 1.56.

Curaleaf (OTCMKTS:CURLF) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.27 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.24) by $0.51. Curaleaf had a negative return on equity of 8.11% and a negative net margin of 7.76%.The firm had revenue of $324.23 million for the quarter, compared to analysts’ expectations of $316.62 million. As a group, research analysts anticipate that Curaleaf Holdings, Inc. will post -0.31 EPS for the current year.

About Curaleaf

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.